CA2473097A1 - Compositions including ammonia oxidizing bacteria and methods of using same - Google Patents

Compositions including ammonia oxidizing bacteria and methods of using same Download PDF

Info

Publication number
CA2473097A1
CA2473097A1 CA002473097A CA2473097A CA2473097A1 CA 2473097 A1 CA2473097 A1 CA 2473097A1 CA 002473097 A CA002473097 A CA 002473097A CA 2473097 A CA2473097 A CA 2473097A CA 2473097 A1 CA2473097 A1 CA 2473097A1
Authority
CA
Canada
Prior art keywords
bacteria
nitric oxide
subject
nitrite
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002473097A
Other languages
English (en)
French (fr)
Inventor
David R. Whitlock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2473097A1 publication Critical patent/CA2473097A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/40—Viruses, e.g. bacteriophages
    • A—HUMAN NECESSITIES
    • A41—WEARING APPAREL
    • A41B—SHIRTS; UNDERWEAR; BABY LINEN; HANDKERCHIEFS
    • A41B17/00—Selection of special materials for underwear
    • A—HUMAN NECESSITIES
    • A41—WEARING APPAREL
    • A41D—OUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
    • A41D31/00—Materials specially adapted for outerwear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/84—Accessories, not otherwise provided for, for absorbent pads
    • A61F13/8405—Additives, e.g. for odour, disinfectant or pH control
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A41—WEARING APPAREL
    • A41B—SHIRTS; UNDERWEAR; BABY LINEN; HANDKERCHIEFS
    • A41B2400/00—Functions or special features of shirts, underwear, baby linen or handkerchiefs not provided for in other groups of this subclass
    • A41B2400/34—Functions or special features of shirts, underwear, baby linen or handkerchiefs not provided for in other groups of this subclass antimicrobial or antibacterial
    • A—HUMAN NECESSITIES
    • A41—WEARING APPAREL
    • A41D—OUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
    • A41D31/00—Materials specially adapted for outerwear
    • A41D31/04—Materials specially adapted for outerwear characterised by special function or use
    • A41D31/30—Antimicrobial, e.g. antibacterial
    • A—HUMAN NECESSITIES
    • A41—WEARING APPAREL
    • A41D—OUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
    • A41D31/00—Materials specially adapted for outerwear
    • A41D31/04—Materials specially adapted for outerwear characterised by special function or use
    • A41D31/30—Antimicrobial, e.g. antibacterial
    • A41D31/305—Antimicrobial, e.g. antibacterial using layered materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/114—Nitric oxide, i.e. NO
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/30—Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Textile Engineering (AREA)
  • Materials Engineering (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Wood Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Agronomy & Crop Science (AREA)
  • Endocrinology (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
CA002473097A 2002-01-11 2003-01-13 Compositions including ammonia oxidizing bacteria and methods of using same Abandoned CA2473097A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US34776002P 2002-01-11 2002-01-11
US60/347,760 2002-01-11
US37568002P 2002-04-26 2002-04-26
US60/375,680 2002-04-26
US41366702P 2002-09-24 2002-09-24
US60/413,667 2002-09-24
PCT/US2003/000995 WO2003057380A2 (en) 2002-01-11 2003-01-13 Compositions including ammonia oxidizing bacteria and methods of using same

Publications (1)

Publication Number Publication Date
CA2473097A1 true CA2473097A1 (en) 2003-07-17

Family

ID=27407793

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002473097A Abandoned CA2473097A1 (en) 2002-01-11 2003-01-13 Compositions including ammonia oxidizing bacteria and methods of using same

Country Status (9)

Country Link
US (2) US20050244382A9 (enExample)
EP (1) EP1472021A4 (enExample)
JP (1) JP2005515218A (enExample)
KR (1) KR20040086267A (enExample)
CN (1) CN1308438C (enExample)
AU (1) AU2003222569A1 (enExample)
BR (1) BR0306868A (enExample)
CA (1) CA2473097A1 (enExample)
WO (1) WO2003057380A2 (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080085515A1 (en) * 2000-03-24 2008-04-10 Eppendorf Array Technologies Sa (Eat) Identification of multiple biological (micro) organisms by detection of their nucleotide sequences on arrays
US7205104B2 (en) * 2000-03-24 2007-04-17 Eppendorf Array Technologies Sa (Eat) Identification of biological (micro) organisms by detection of their homologous nucleotide sequences on arrays
US7875442B2 (en) * 2000-03-24 2011-01-25 Eppendorf Array Technologies Identification and quantification of a plurality of biological (micro)organisms or their components
US7829313B2 (en) 2000-03-24 2010-11-09 Eppendorf Array Technologies Identification and quantification of a plurality of biological (micro)organisms or their components
US7202026B2 (en) * 2000-03-24 2007-04-10 Eppendorf Array Technologies Sa (Eat) Identification of a large number of biological (micro)organisms groups at different levels by their detection on a same array
EP1164201A1 (en) * 2000-06-14 2001-12-19 Facultés Universitaires Notre-Dame de la Paix Reverse detection for identification and/or quantification of nucleotide target sequences on biochips
CN1267212C (zh) 2000-08-11 2006-08-02 大卫·R·怀特洛克 氨氧化细菌在药物中的应用、由其制成的制剂及用其处理过的用品
JP2007508247A (ja) * 2003-09-26 2007-04-05 ホイットロック，デービッド，アール． アンモニア酸化細菌の使用方法
AU2005247437B2 (en) * 2004-05-24 2010-05-27 Valent Biosciences Corporation Stable and water-soluble plant growth regulator liquid compositions and methods for use of same
US7338763B2 (en) * 2004-06-02 2008-03-04 Eppendorf Array Technologies S.A. Method and kit for the detection and/or quantification of homologous nucleotide sequences on arrays
GB2472790A (en) * 2009-08-18 2011-02-23 Laurence Christian Hayes Dermatological preparations comprising microbes.
CN102586121B (zh) * 2012-02-21 2013-07-10 淮海工学院 一种产乙酰胆碱酯酶抑制剂的真菌及其用途
US11225640B2 (en) 2014-04-15 2022-01-18 Aobiome Llc Ammonia oxidizing bacteria for treatment of psoriasis
WO2015160911A2 (en) * 2014-04-15 2015-10-22 Aobiome Llc Ammonia-oxidizing nitrosomonas eutropha strain d23
JP7088986B2 (ja) * 2014-04-15 2022-06-21 エーオーバイオーム， エルエルシー． アンモニア酸化Ｎｉｔｒｏｓｏｍｏｎａｓ ｅｕｔｒｏｐｈａ株Ｄ２３
WO2015179669A1 (en) * 2014-05-22 2015-11-26 Aobiome Llc Methods of preparing materials with ammonia oxidizing bacteria and testing materials for ammonia oxidizing bacteria
AU2015264068A1 (en) * 2014-05-22 2016-12-08 Aobiome Llc Systems and methods for storage and delivery of ammonia oxidizing bacteria
WO2016161285A1 (en) * 2015-04-02 2016-10-06 Aobiome Llc Production of nitro-fatty acids and nitro-hydrocarbons by ammonia oxidizing bacteria
MX386941B (es) * 2015-07-02 2025-03-19 Aobiome Llc Bacterias oxidantes de amoniaco para el tratamiento del acné.
AU2016287746A1 (en) * 2015-07-02 2018-01-25 Aobiome Llc Microbiome-compatible cosmetics
US11886477B2 (en) 2015-09-22 2024-01-30 Northern Light Group, Llc System and method for quote-based search summaries
US11544306B2 (en) 2015-09-22 2023-01-03 Northern Light Group, Llc System and method for concept-based search summaries
US11226946B2 (en) 2016-04-13 2022-01-18 Northern Light Group, Llc Systems and methods for automatically determining a performance index
CN109689076A (zh) * 2016-07-19 2019-04-26 Ao生物医学有限责任公司 用于胃肠系统使用和递送至胃肠系统的氨氧化微生物
US20200008299A1 (en) * 2016-10-21 2020-01-02 Bao Tran Flexible printed electronics
JP2020503286A (ja) * 2016-12-12 2020-01-30 エーオーバイオーム， エルエルシー．ＡＯＢｉｏｍｅ， ＬＬＣ． 血圧の調節のためのアンモニア酸化微生物
TW201907934A (zh) * 2017-07-18 2019-03-01 美商微辰生命有限公司 用於治療肺動脈高血壓之氨氧化微生物
WO2019018425A1 (en) * 2017-07-18 2019-01-24 Aobiome Llc AMMONIA-OXIDIZING MICROORGANISMS FOR INJECTION USE AND ADMINISTRATION
EP3654998A4 (en) * 2017-07-18 2021-04-21 Aobiome LLC MICRO-ORGANISMS FOR USE AND PROVISION TO THE RESPIRATORY SYSTEM
US20200179461A1 (en) * 2017-07-18 2020-06-11 Aobiome Llc Ammonia oxidizing microorganisms for the treatment of headaches
US20210369599A1 (en) * 2017-11-22 2021-12-02 Aobiome Llc Topical use and delivery of ammonia oxidizing microorganisms
US20210361560A1 (en) * 2017-11-22 2021-11-25 Aobiome Llc Topical use and delivery of ammonia oxidizing microorganisms
US20210052672A1 (en) * 2018-03-30 2021-02-25 Aobiome Llc Use and delivery of ammonia oxidizing microorganisms for treatment of neurodegenerative disorders
JP7520366B2 (ja) 2018-04-16 2024-07-23 オンクオリティー ファーマシューティカルズ チャイナ リミテッド 腫瘍療法の副作用の予防または治療方法
US20220202880A1 (en) * 2019-05-07 2022-06-30 Aobiome Llc Preparations of ammonia oxidizing microorganisms and related products

Family Cites Families (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3984575A (en) * 1974-02-06 1976-10-05 Microlife Technics, Inc. Bacterial compositions for changing the digestive system bacteria in animals
US4147807A (en) * 1977-09-06 1979-04-03 Microlife Technics, Inc. Process for the treatment of meat with compositions including Micrococcus varians and a lactic acid producing bacteria
US4335107A (en) * 1978-06-05 1982-06-15 Snoeyenbos Glenn H Mixture to protect poultry from salmonella
FI59925C (fi) * 1980-01-11 1981-11-10 Esko Viljo Nurmi Foerfarande foer framstaellning av ett bakteriepreparat anvaendbart foer foerhindrande av salmonellainfektion hos fjaederfae
US4720344A (en) * 1985-04-18 1988-01-19 Ganczarczyk Jerzy J Nitrification process in waste water treatment
IT1227154B (it) * 1988-08-05 1991-03-19 A Tosi Farmaceutici S R L Nova Composizioni farmaceutiche per uso ginecologico a base di lattobacilli
SE465206B (sv) * 1989-12-22 1991-08-12 Eva Grahn Farmaceutisk beredning foer bekaempning av patogena tarmbakterier
US5139792A (en) * 1990-07-19 1992-08-18 Bio-Techniques Laboratories, Inc. Method and system for dispensing live bacteria into animal feed and drinking water
US5570683A (en) * 1990-12-05 1996-11-05 The General Hospital Corporation Methods and devices for treating pulmonary vasoconstriction and asthma
US5396882A (en) * 1992-03-11 1995-03-14 The General Hospital Corporation Generation of nitric oxide from air for medical uses
DE122007000103I1 (de) * 1990-12-05 2008-04-03 Gen Hospital Corp Verwendung von NO zur Behandlung der persistenten pulmonalen Hypertonie des Neugeborenen
US5380758A (en) * 1991-03-29 1995-01-10 Brigham And Women's Hospital S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof
US5455279A (en) * 1991-04-19 1995-10-03 The Children's Medical Center Corporation Regimen method of mediating neuronal damage using nitroglycerine
DE69334101T2 (de) * 1992-02-07 2007-10-04 Vasogen Ireland Ltd., Shannon Verwendung von Blut mit erhöhter Stickoxidkonzentration zur Herstellung eines Medikaments
US5814666A (en) * 1992-04-13 1998-09-29 The United States As Represented By The Department Of Health And Human Services Encapsulated and non-encapsulated nitric oxide generators used as antimicrobial agents
US5278192A (en) * 1992-07-02 1994-01-11 The Research Foundation Of State University Of New York Method of vasodilator therapy for treating a patient with a condition
US5646181A (en) * 1992-07-02 1997-07-08 Research Foundation Of State University Of New York Method and compositions for treating impotence
US5340577A (en) * 1992-07-29 1994-08-23 The United States Of America, As Represented By The Secretary Of Agriculture Probiotic for control of salmonella
US5910316A (en) * 1992-08-24 1999-06-08 The United States Of America, As Represented By The Department Of Health And Human Services Use of nitric oxide-releasing agents to treat impotency
US5650447A (en) * 1992-08-24 1997-07-22 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Nitric oxide-releasing polymers to treat restenosis and related disorders
US5632981A (en) * 1992-08-24 1997-05-27 The United States Of America As Represented By The Department Of Health And Human Services Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
US5385940A (en) * 1992-11-05 1995-01-31 The General Hospital Corporation Treatment of stroke with nitric-oxide releasing compounds
CA2156486C (en) * 1993-03-16 2002-11-12 Norman J. Stern Mucosal competitive exclusion flora
US5427797A (en) * 1993-04-06 1995-06-27 Brigham And Women's Hospital Systemic effects of nitric oxide inhalation
GB2279014B (en) * 1993-06-02 1997-07-16 Niall Keaney Device for controlling delivery of respiratory drugs
US5861168A (en) * 1993-06-11 1999-01-19 The Board Of Trustees Of The Leland Stanford Junior University Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury
US5314542A (en) * 1993-08-06 1994-05-24 Precision Aquarium Testing, Inc. Nitrosomonas preservation and reactivation for aquaria
US6087479A (en) * 1993-09-17 2000-07-11 Nitromed, Inc. Localized use of nitric oxide-adducts to prevent internal tissue damage
US5728705A (en) * 1993-10-04 1998-03-17 The Trustees Of Columbia University In The City Of New York Method of inducing vasorelaxation to treat pulmonary hypertension
GB9320978D0 (en) * 1993-10-12 1993-12-01 Higenbottam Timohy W Nitric oxide treatment
EP0726768B1 (en) * 1993-11-02 2000-05-17 THE UNITED STATES OF AMERICA, represented by THE SECRETARY, Department of Health and Human Services Use of nitric oxide releasing compounds for the manufacture of a medicament for protection in ischemia reperfusion injury
US5470847A (en) * 1993-12-10 1995-11-28 Board Of Regents, The University Of Texas System Ovulation control by regulating nitric oxide levels with arginine derivatives
US5384030A (en) * 1994-02-15 1995-01-24 General Motors Corporation Exhaust sensor including a composite tile sensing element and methods of making the same
ES2092460T3 (es) * 1994-05-27 2001-02-01 Cellegy Pharma Inc Composicion dadora de oxido nitrico para el tratamiento de trastornos anales.
US5543430A (en) * 1994-10-05 1996-08-06 Kaesemeyer; W. H. Method and formulation of stimulating nitric oxide synthesis
US5519020A (en) * 1994-10-28 1996-05-21 The University Of Akron Polymeric wound healing accelerators
US5648101A (en) * 1994-11-14 1997-07-15 Tawashi; Rashad Drug delivery of nitric oxide
EP0799051B1 (en) * 1994-12-12 2005-07-27 Omeros Corporation Irrigation solution and use thereof for perioperatively inhibiting pain, inflammation and spasm at a wound
US6063407A (en) * 1995-02-16 2000-05-16 The General Hospital Corporation Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
US5595753A (en) * 1995-04-14 1997-01-21 President And Fellows Of Harvard College Topical formulations and methods for treating hemorrhoidal pain and sphincter and smooth muscle spasm in the gastrointestinal tract
US5665077A (en) * 1995-04-24 1997-09-09 Nitrosci Pharmaceuticals Llc Nitric oxide-releasing nitroso compositions and methods and intravascular devices for using them to prevent restenosis
JPH08298982A (ja) * 1995-05-02 1996-11-19 Aasu Giken:Kk 複合微生物製剤
US5645839A (en) * 1995-06-07 1997-07-08 Trustees Of Boston University Combined use of angiotensin inhibitors and nitric oxide stimulators to treat fibrosis
US5534253A (en) * 1995-06-07 1996-07-09 Biogaia Ab Method of treating enteropathogenic bacterial infections in poultry
US5900433A (en) * 1995-06-23 1999-05-04 Cormedics Corp. Vascular treatment method and apparatus
US5714511A (en) * 1995-07-31 1998-02-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Selective prevention of organ injury in sepsis and shock using selection release of nitric oxide in vulnerable organs
US5876603A (en) * 1995-08-10 1999-03-02 Hitachi Plant Engineering & Construction Co., Ltd. Method of biologically removing nitrogen and system therefor
DE19654895C2 (de) * 1996-02-07 2000-07-27 Sanol Arznei Schwarz Gmbh Detektionsverfahren
US5849192A (en) * 1996-02-12 1998-12-15 Basf Corporation Procedure to recover from nitrification upsets
US5725492A (en) * 1996-03-04 1998-03-10 Cormedics Corp Extracorporeal circulation apparatus and method
US5910482A (en) * 1996-03-19 1999-06-08 Board Of Regents, The University Of Texas System Treatment or prevention of preeclampsia, eclampsia with calcitonin gene related peptide, CGRP analog, progestational agent, nitric oxide source, and cyclooxygenase inhibitor
US5824669A (en) * 1996-03-22 1998-10-20 Nitromed, Inc. Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
US5765548A (en) * 1996-05-07 1998-06-16 Perry; Bryan J. Use of nitric oxide in the treatment of exercised induced pulmonary hemorrhaging in equine
US6057367A (en) * 1996-08-30 2000-05-02 Duke University Manipulating nitrosative stress to kill pathologic microbes, pathologic helminths and pathologically proliferating cells or to upregulate nitrosative stress defenses
US5821112A (en) * 1996-10-04 1998-10-13 Botto; Willism S. Biological odor metabolizing compositions and methods of use
US5807546A (en) * 1996-10-11 1998-09-15 The United States Of America As Represented By The Secretary Of Agriculture Livestock mucosal competitive exclusion culture to reduce enteropathogenic bacteria
US5958427A (en) * 1996-11-08 1999-09-28 Salzman; Andrew L. Nitric oxide donor compounds and pharmaceutical compositions for pulmonary hypertension and other indications
US5891472A (en) * 1996-11-19 1999-04-06 Meri Charmyne Russell Treatment of equine laminitis
FR2764802A1 (fr) * 1996-12-24 1998-12-24 Standa Lab Sa Composition adsorbable renfermant des bacteries propioniques susceptible de degager du monoxyde d'azote dans le tube digestif humain ou animal
US20050036996A1 (en) * 1996-12-24 2005-02-17 Edmond Roussel Absorbable composition containing propionic bacteria capable of releasing nitric oxide in the human or animal alimentary canal
US5912019A (en) * 1997-02-07 1999-06-15 Musc Foundation For Research Development Compounds for reducing ischemia/reperfusion injury
US6087087A (en) * 1997-07-03 2000-07-11 Takashi Yonetani Treatment of hemoglobin with nitric oxide
US5895658A (en) * 1997-09-17 1999-04-20 Fossel; Eric T. Topical delivery of L-arginine to cause tissue warming
US5994444A (en) * 1997-10-16 1999-11-30 Medtronic, Inc. Polymeric material that releases nitric oxide
US6056966A (en) * 1998-05-18 2000-05-02 Baker Norton Pharmaceuticals, Inc. Method and compositions for treating impotence
US6080401A (en) * 1998-11-19 2000-06-27 Reddy; Malireddy S. Herbal and pharmaceutical drugs enhanced with probiotics
CN1267212C (zh) * 2000-08-11 2006-08-02 大卫·R·怀特洛克 氨氧化细菌在药物中的应用、由其制成的制剂及用其处理过的用品

Also Published As

Publication number Publication date
CN1630710A (zh) 2005-06-22
JP2005515218A (ja) 2005-05-26
AU2003222569A1 (en) 2003-07-24
EP1472021A2 (en) 2004-11-03
US20050244382A9 (en) 2005-11-03
EP1472021A4 (en) 2008-04-16
US20050106126A1 (en) 2005-05-19
CN1308438C (zh) 2007-04-04
BR0306868A (pt) 2005-04-12
WO2003057380A3 (en) 2003-12-04
WO2003057380A2 (en) 2003-07-17
US20080213226A1 (en) 2008-09-04
KR20040086267A (ko) 2004-10-08

Similar Documents

Publication Publication Date Title
US20080213226A1 (en) Compositions including ammonia oxidizing bacteria and methods of using same
US8388989B2 (en) Articles of clothing treated with ammonia oxidizing bacteria to produce nitric oxide
AU2001284849A1 (en) Compositions including ammonia oxidizing bacteria to increase production of nitric oxide and nitric oxide precursors and methods of using same
US20240279709A1 (en) Methods of preparing materials with ammonia oxidizing bacteria and testing materials for ammonia oxidizing bacteria
CN107429213A (zh) 储存和递送氨氧化细菌的系统和方法
Turner Counter-irritant and other medicinal uses of plants in Ranunculaceae by native peoples in British Columbia and neighbouring areas
KR20180022934A (ko) 좌창의 치료를 위한 암모니아 산화 박테리아
Armstrong The water of life: a treatise on urine therapy
US20250143351A1 (en) Veterinary use and delivery of ammonia oxidizing microorganisms
BR122015019488B1 (pt) Non-therapeutic cosmetic nitric oxide supply method for a individual understanding the application of ammonia oxiding bacteria
HK1059407A (en) Compositions including ammonia oxidizing bacteria to increase production of nitric oxide and nitric oxide precursors and methods of using same
Fullerton The family medical guide
Amin In their own words OR: symptoms of Morgellons and Neuro-cutaneous Syndrome (NCS) upon first examination at the Parasitology Center, Inc.(PCI)
Peters BMA Home Doctor
CN100352451C (zh) 一种治疗和预防口蹄疫的组合物
De Vries Skin Diseases
Elkan-Ho Self-Help to Cheat Death
Dunlop Six Cases of Myxœdema Treated by Thyroid Feeding
Wehman Family Medical Instructor: A Hand-Book of practical Information and ready Reference in Illness. Compiled From the Most Reliable Sources. By Henry J. Wehman

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued